Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

NCT00110422 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT00110422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00110422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2005
Completion date
February 28, 2007
Enrollment
400
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, metabolic syndrome